Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-18 Sale | 2023-01-20 4:34 pm | Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer | 2,008 | $26.89 | $53,995 | 169,538 (Direct) | View |
| 2022-10-18 Sale | 2022-10-20 4:54 pm | Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer | 1,703 | $25.2 | $42,916 | 171,546 (Direct) | View |
| 2022-07-18 Sale | 2022-07-20 4:37 pm | Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer | 1,704 | $12.87 | $21,930 | 173,249 (Direct) | View |
| 2022-04-19 Sale | 2022-04-21 4:25 pm | Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer | 7,049 | $10.45 | $73,662 | 174,953 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-25 Option Award | 2024-03-28 12:36 pm | 2025-03-25 2034-03-25 | ESSA Pharma Inc. | EPIX | Merendino Lauren Director | 25,000 | $0 | 25,000 (Direct) | View |
Ownership | 2023-06-06 4:30 pm | N/A 2033-06-05 | ESSA Pharma Inc. | EPIX | Merendino Lauren Director | 0 | $0 | 50,000 (Direct) | View |
| 2023-03-10 Disposition | 2023-03-10 09:31 am | N/A 2031-04-14 | Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer | 396,541 | $0 | 0 (Direct) | View |
| 2022-04-15 Option Award | 2022-04-19 4:48 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer | 103,703 | $0 | 182,002 (Direct) | View |
| 2021-04-15 Option Award | 2021-04-19 4:13 pm | N/A 2031-04-14 | Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer | 201,599 | $0 | 201,599 (Direct) | View |
Ownership | 2021-04-08 4:48 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer | 0 | $0 | 0 (Direct) | View |